[{"Assets_0_FY_USD":671021000.0,"CommonStockSharesOutstanding_0_FY_shares":21148665.0,"EarningsPerShareBasic_1_FY_USD":-0.33,"EarningsPerShareBasic_4_FY_USD":0.6,"EarningsPerShareDiluted_1_FY_USD":-0.33,"EarningsPerShareDiluted_4_FY_USD":0.53,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":93568000.0,"NetIncomeLoss_1_FY_USD":-7007000.0,"NetIncomeLoss_4_FY_USD":12556000.0,"StockholdersEquity_0_FY_USD":399788000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":21109000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":23481000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":21109000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":21032000.0,"Ticker":"LGND","CIK":"886163","name":"LIGAND PHARMACEUTICALS INC","OfficialName":"Ligand Pharmaceuticals Incorporated Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1738856427.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180301"}]